Literature DB >> 19615555

Genetic testing: considerations for pediatric nephrologists.

Lisa M Guay-Woodford1, Nine V A M Knoers.   

Abstract

With the completion of the Human Genome Project and the associated advances in genomic technologies, clinicians have at their disposal an increasing repertoire of tools to provide accurate and efficient diagnosis, assess disease predisposition and risk factors, and personalize therapeutic management. To date, more than 2,000 human disease genes have been identified, including genes involved in single-gene disorders that disrupt the structure and/or function of the kidney and developing urinary tract. The use of genetic tests for diagnostic purposes increasingly is being integrated into general medical practice and therefore it is important for clinicians to be familiar with the technical approaches and ethical implications of these methods. Here, we provide an overview of the utility and limitations of current genetic tests for diagnosis, prenatal examination, carrier detection, and presymptomatic testing of hereditary disorders, with emphasis on pediatric renal disorders. In addition, we describe new technical advances that are expected to be introduced into clinical practice in the coming years.

Entities:  

Mesh:

Year:  2009        PMID: 19615555     DOI: 10.1016/j.semnephrol.2009.03.010

Source DB:  PubMed          Journal:  Semin Nephrol        ISSN: 0270-9295            Impact factor:   5.299


  3 in total

Review 1.  Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice.

Authors:  Kimberly A Kaphingst; Colleen M McBride
Journal:  Semin Nephrol       Date:  2010-03       Impact factor: 5.299

2.  Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and families.

Authors:  M Reiff; K Ross; S Mulchandani; K J Propert; R E Pyeritz; N B Spinner; B A Bernhardt
Journal:  Clin Genet       Date:  2012-09-18       Impact factor: 4.438

Review 3.  Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown Etiology.

Authors:  Amber de Haan; Mark Eijgelsheim; Liffert Vogt; Nine V A M Knoers; Martin H de Borst
Journal:  Front Genet       Date:  2019-12-13       Impact factor: 4.599

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.